Survivorship clinical trials

Explore recruiting survivorship clinical trials.

Recruiting survivorship studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Survivorship trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EORTC 1634-BTG (NOA-23): Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly Diagnosed Medulloblastoma (PersoMed-I)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)

Ireland, Sweden, Norway, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Survivorship trials by city

Survivorship in Toronto Survivorship in Vancouver Survivorship in Montreal Survivorship in Calgary Survivorship in Edmonton Survivorship in Ottawa Survivorship in Winnipeg Survivorship in Quebec City Survivorship in Hamilton Survivorship in Kitchener Survivorship in London Survivorship in Halifax Survivorship in New York Survivorship in Los Angeles Survivorship in Chicago Survivorship in Houston

Survivorship clinical trials

Recruiting survivorship studies right now

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation

Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)

Stress Reduction Through Acupuncture

Also recruiting in Europe

EORTC 1634-BTG (NOA-23): Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly Diagnosed Medulloblastoma (PersoMed-I)

NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)

Survivorship trials by city

Other conditions